AksharChem (I)
AksharChem (I) Q2 FY27 results statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and projects.
Based on AksharChem (I)'s Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
For the quarter ended September 30, 2026, revenue from operations was Rs. For the quarter ended September 30, 2026, Aksharchem reported: - EBITDA: Rs.
From AksharChem (I)'s Q2 FY27 earnings-call transcript · updated 20 Oct 2026.
Revenue & Sales Performance
- For the quarter ended September 30, 2026, revenue from operations was Rs. 16,048.24 lakhs.
- For the quarter ended September 30, 2025, revenue from operations was Rs. 8,930.24 lakhs.
- Year-on-year revenue growth for the quarter is approximately 79.7% [(16,048.24 - 8,930.24) / 8,930.24 * 100].
2 more points from AksharChem (I)'s call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what AksharChem (I) said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what AksharChem (I) said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from AksharChem (I)'s call on order book
Pro opens every point from 15K+ earnings calls
AksharChem (I) — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹160 Cr, net profit ₹13 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What AksharChem (I)'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- GOCL Corpn. (Q2 FY27)
Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result
- Bhansali Engineering Polymers Ltd (Q2 FY27)
Revenue from operations (net) for the quarter ended 30/09/2026 is ₹40,336.95 lakhs, compared to ₹32,509.76 lakhs for the quarter ended 30/09/2025, reflecting a…
- Tatva Chintan (Q2 FY27)
Q2 FY27 revenue from operations: ₹2,173 Mn, up 76% YoY from ₹1,235 Mn in Q2 FY26 (Page 11). Key investor presentation takeaways from Tatva Chintan's Q2 FY27 inv
- Rossari Biotech (Q2 FY27)
4,195.12 million, an increase of approximately 18%. Key investor presentation takeaways from Rossari Biotech's Q2 FY27 investor presentation — and how it ranks
Arthneeti Pro · Annual
AksharChem (I) and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were AksharChem (I) Q2 FY27 results?
For the quarter ended September 30, 2026, revenue from operations was Rs. For the quarter ended September 30, 2026, Aksharchem reported: - EBITDA: Rs.
What is AksharChem (I) share price analysis?
AksharChem (I) currently shows a neutral. The stock trades at a P/E of 26.9 with a market cap of ₹333 Cr. Investors should review the full earnings analysis for detailed insights.
Is AksharChem (I) planning capital expenditure?
The presentation does not provide specific details on capex, capacity expansion, or new plant/project amounts, status, or timelines.
Keep AksharChem (I) on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.